T cell recognition as the target for immune intervention in autoimmune disease

[1]  E. Heber-Katz,et al.  Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein , 1988, The Journal of experimental medicine.

[2]  U Gyllensten,et al.  HLA class II allelic variation and susceptibility to pemphigus vulgaris. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. Cohen.  Regulation of Autoimmune Disease Physiological and Therapeutic , 1986, Immunological reviews.

[4]  R. Hohlfeld,et al.  Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis. , 1988, The Journal of clinical investigation.

[5]  L. Hood,et al.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.

[6]  R. Schwartz.  Immune response (Ir) genes of the murine major histocompatibility complex. , 1986, Advances in immunology.

[7]  J. Todd,et al.  A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. , 1988, Trends in genetics : TIG.

[8]  L. Cavalli-Sforza,et al.  T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Todd,et al.  A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. , 1988, Science.

[10]  E. Unanue,et al.  Binding of immunogenic peptides to Ia histocompatibility molecules , 1985, Nature.

[11]  H. Mcdevitt,et al.  Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[13]  L. Hood,et al.  Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice , 1988, The Journal of experimental medicine.

[14]  I. Cohen,et al.  Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. , 1988, Science.

[15]  J. Sprent,et al.  T Cell Selection in the Thymus , 1988, Immunological reviews.

[16]  A. O’Garra.  INTERLEUKINS AND THE IMMUNE SYSTEM 2 , 1989, The Lancet.

[17]  S. Krane,et al.  Clonal dominance among T-lymphocyte infiltrates in arthritis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Seidman,et al.  Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis [published erratum appears in J Exp Med 1988 Jul 1;168(1):459] , 1988, The Journal of experimental medicine.

[19]  D. Wiley,et al.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[20]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[21]  A Sette,et al.  Immunological self, nonself discrimination. , 1987, Science.

[22]  L. Hood,et al.  The germline repertoire of T cell receptor β-chain genes in patients with chronic progressive multiple sclerosis , 1989, Journal of Neuroimmunology.

[23]  J. R. Smith,et al.  An extended HLA-D region haplotype associated with celiac disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. O’Garra.  Interleukins and the immune system 1. , 1989, Lancet.

[25]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[26]  P. Marrack,et al.  The T-cell repertoire for antigen and MHC. , 1988, Immunology today.

[27]  J. Claverie,et al.  The peptidic self model: a hypothesis on the molecular nature of the immunological self. , 1986, Annales de l'Institut Pasteur. Immunology.

[28]  E. Unanue,et al.  Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Rothbard,et al.  In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. , 1988, The Journal of clinical investigation.

[30]  H. Grey,et al.  Autologous peptides constitutively occupy the antigen binding site on Ia. , 1988, Science.

[31]  Lawrence Steinman,et al.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.

[32]  J. Rothbard,et al.  A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. , 1988, The Journal of clinical investigation.

[33]  K. Yamamura,et al.  Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice , 1987, Nature.

[34]  J. Kapp,et al.  Genetics of insulin-specific helper and suppressor T cells in nonresponder mice. , 1985, Journal of immunology.

[35]  H. Luthra,et al.  Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice , 1988, The Journal of experimental medicine.

[36]  I. Todd,et al.  Organ‐Specific Autoimmunity: A 1986 Overview , 1986, Immunological reviews.

[37]  F. Cardinaux,et al.  In vivo competition between self peptides and foreign antigens in T-cell activation , 1988, Nature.

[38]  N. Shen,et al.  Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different , 1989, The Journal of experimental medicine.

[39]  H. von Boehmer,et al.  The thymus selects the useful, neglects the useless and destroys the harmful. , 1989, Immunology today.